ATTO
Attovia Therapeutics, Inc.
123 disclosed insider filings · 7 distinct insiders · latest Aug 28, 2026
Total filings
123
7 insiders
Insider buys
13
$73M
Insider sells
92
$9.0M
Grants & other
0
$0
All disclosed filings
Same-day tranches are grouped per insider - the Lots column shows how many individual executions a row covers; Price is the value-weighted average.
| Filed | Tx date | Insider | Type | Qty | Avg price | Value | Lots | Source |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Aug 6, 2026 | Goldman Sachs Group Inc INSIDER | BUY | 1,000,000 | $17 | $17M | 2 | EDGAR |
| Aug 28, 2026 | Aug 6, 2026 | Colin Walsh DIRECTOR | OTHER | 4,871,264 | — | — | 4 | EDGAR |
| Aug 28, 2026 | Aug 6, 2026 | Goldman Sachs Group Inc INSIDER | OTHER | 4,871,264 | — | — | 4 | EDGAR |
| Aug 28, 2026 | Aug 6, 2026 | Colin Walsh DIRECTOR | BUY | 1,000,000 | $17 | $17M | 2 | EDGAR |
| Aug 28, 2026 | Aug 5, 2026 | Colin Walsh DIRECTOR | BUY | 170,000 | $21 | $3.6M | 2 | EDGAR |
| Aug 28, 2026 | Aug 5, 2026 | Goldman Sachs Group Inc INSIDER | SELL | 211,614 | $21.28 | $4.5M | 46 | EDGAR |
| Aug 28, 2026 | Aug 5, 2026 | Goldman Sachs Group Inc INSIDER | BUY | 170,000 | $21 | $3.6M | 2 | EDGAR |
| Aug 28, 2026 | Aug 5, 2026 | Colin Walsh DIRECTOR | SELL | 211,614 | $21.28 | $4.5M | 46 | EDGAR |
| Aug 10, 2026 | Aug 6, 2026 | Venbio Global Strategic Fund Iv L P INSIDER | BUY | 382,352 | $17 | $6.5M | — | EDGAR |
| Aug 10, 2026 | Aug 6, 2026 | Deep Track Biotechnology Master Fund Ltd INSIDER | OTHER | 1,957,138 | — | — | — | EDGAR |
| Aug 10, 2026 | Aug 6, 2026 | Venbio Global Strategic Fund Iv L P INSIDER | OTHER | 3,799,015 | — | — | 3 | EDGAR |
| Aug 7, 2026 | Aug 6, 2026 | Sanofi INSIDER | OTHER | 782,855 | — | — | — | EDGAR |
| Aug 7, 2026 | Aug 6, 2026 | Redmile Group LLC 10% OWNER | BUY | 600,000 | $17 | $10M | 2 | EDGAR |
| Aug 7, 2026 | Aug 6, 2026 | Redmile Group LLC 10% OWNER | OTHER | 782,854 | — | — | — | EDGAR |
| Aug 7, 2026 | Aug 6, 2026 | Sanofi INSIDER | BUY | 300,000 | $17 | $5.1M | — | EDGAR |
| Aug 6, 2026 | Aug 6, 2026 | Frazier Life Sciences Xi L P INSIDER | BUY | 588,235 | $17 | $10.0M | — | EDGAR |
| Aug 6, 2026 | Aug 6, 2026 | Frazier Life Sciences Xi L P INSIDER | OTHER | 5,490,629 | — | — | 4 | EDGAR |